These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 36901113)

  • 1. Uncertainty Quantification for Epidemic Risk Management: Case of SARS-CoV-2 in Morocco.
    Hammadi L; Raillani H; Ndiaye BM; Aggoug B; El Ballouti A; Jidane S; Belyamani L; Souza de Cursi E
    Int J Environ Res Public Health; 2023 Feb; 20(5):. PubMed ID: 36901113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complex model calibration through emulation, a worked example for a stochastic epidemic model.
    Dunne M; Mohammadi H; Challenor P; Borgo R; Porphyre T; Vernon I; Firat EE; Turkay C; Torsney-Weir T; Goldstein M; Reeve R; Fang H; Swallow B
    Epidemics; 2022 Jun; 39():100574. PubMed ID: 35617882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Uncertainty and error in SARS-CoV-2 epidemiological parameters inferred from population-level epidemic models.
    Whittaker DG; Herrera-Reyes AD; Hendrix M; Owen MR; Band LR; Mirams GR; Bolton KJ; Preston SP
    J Theor Biol; 2023 Feb; 558():111337. PubMed ID: 36351493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-pharmacological measures implemented in the setting of long-term care facilities to prevent SARS-CoV-2 infections and their consequences: a rapid review.
    Stratil JM; Biallas RL; Burns J; Arnold L; Geffert K; Kunzler AM; Monsef I; Stadelmaier J; Wabnitz K; Litwin T; Kreutz C; Boger AH; Lindner S; Verboom B; Voss S; Movsisyan A
    Cochrane Database Syst Rev; 2021 Sep; 9(9):CD015085. PubMed ID: 34523727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Travel-related control measures to contain the COVID-19 pandemic: a rapid review.
    Burns J; Movsisyan A; Stratil JM; Coenen M; Emmert-Fees KM; Geffert K; Hoffmann S; Horstick O; Laxy M; Pfadenhauer LM; von Philipsborn P; Sell K; Voss S; Rehfuess E
    Cochrane Database Syst Rev; 2020 Oct; 10():CD013717. PubMed ID: 33502002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Importations of COVID-19 into African countries and risk of onward spread.
    Sun H; Dickens BL; Cook AR; Clapham HE
    BMC Infect Dis; 2020 Aug; 20(1):598. PubMed ID: 32791999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. International travel-related control measures to contain the COVID-19 pandemic: a rapid review.
    Burns J; Movsisyan A; Stratil JM; Biallas RL; Coenen M; Emmert-Fees KM; Geffert K; Hoffmann S; Horstick O; Laxy M; Klinger C; Kratzer S; Litwin T; Norris S; Pfadenhauer LM; von Philipsborn P; Sell K; Stadelmaier J; Verboom B; Voss S; Wabnitz K; Rehfuess E
    Cochrane Database Syst Rev; 2021 Mar; 3(3):CD013717. PubMed ID: 33763851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Universal screening for SARS-CoV-2 infection: a rapid review.
    Viswanathan M; Kahwati L; Jahn B; Giger K; Dobrescu AI; Hill C; Klerings I; Meixner J; Persad E; Teufer B; Gartlehner G
    Cochrane Database Syst Rev; 2020 Sep; 9(9):CD013718. PubMed ID: 33502003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Real-time estimation and forecasting of COVID-19 cases and hospitalizations in Wisconsin HERC regions for public health decision making processes.
    Aravamuthan S; Mandujano Reyes JF; Yandell BS; Döpfer D
    BMC Public Health; 2023 Feb; 23(1):359. PubMed ID: 36803324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.
    Deckert A; Anders S; de Allegri M; Nguyen HT; Souares A; McMahon S; Boerner K; Meurer M; Herbst K; Sand M; Koeppel L; Siems T; Brugnara L; Brenner S; Burk R; Lou D; Kirrmaier D; Duan Y; Ovchinnikova S; Marx M; Kräusslich HG; Knop M; Bärnighausen T; Denkinger C
    Trials; 2021 Jan; 22(1):39. PubMed ID: 33419461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Voluntary risk mitigation behaviour can reduce impact of SARS-CoV-2: a real-time modelling study of the January 2022 Omicron wave in England.
    Brooks-Pollock E; Northstone K; Pellis L; Scarabel F; Thomas A; Nixon E; Matthews DA; Bowyer V; Garcia MP; Steves CJ; Timpson NJ; Danon L
    BMC Med; 2023 Jan; 21(1):25. PubMed ID: 36658548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Uncertainty quantification and sensitivity analysis of COVID-19 exit strategies in an individual-based transmission model.
    Gugole F; Coffeng LE; Edeling W; Sanderse B; de Vlas SJ; Crommelin D
    PLoS Comput Biol; 2021 Sep; 17(9):e1009355. PubMed ID: 34534205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Uncertainty quantification in epidemiological models for the COVID-19 pandemic.
    Taghizadeh L; Karimi A; Heitzinger C
    Comput Biol Med; 2020 Oct; 125():104011. PubMed ID: 33091766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reconciling early-outbreak estimates of the basic reproductive number and its uncertainty: framework and applications to the novel coronavirus (SARS-CoV-2) outbreak.
    Park SW; Bolker BM; Champredon D; Earn DJD; Li M; Weitz JS; Grenfell BT; Dushoff J
    J R Soc Interface; 2020 Jul; 17(168):20200144. PubMed ID: 32693748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simulation of the Final Size of the Evolution Curve of Coronavirus Epidemic in Morocco using the SIR Model.
    Ifguis O; El Ghozlani M; Ammou F; Moutcine A; Abdellah Z
    J Environ Public Health; 2020; 2020():9769267. PubMed ID: 32565842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measures implemented in the school setting to contain the COVID-19 pandemic.
    Krishnaratne S; Littlecott H; Sell K; Burns J; Rabe JE; Stratil JM; Litwin T; Kreutz C; Coenen M; Geffert K; Boger AH; Movsisyan A; Kratzer S; Klinger C; Wabnitz K; Strahwald B; Verboom B; Rehfuess E; Biallas RL; Jung-Sievers C; Voss S; Pfadenhauer LM
    Cochrane Database Syst Rev; 2022 Jan; 1(1):CD015029. PubMed ID: 35037252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Uncertainty quantification of a mathematical model of COVID-19 transmission dynamics with mass vaccination strategy.
    Olivares A; Staffetti E
    Chaos Solitons Fractals; 2021 May; 146():110895. PubMed ID: 33814733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modelling of hypothetical SARS-CoV-2 point-of-care tests on admission to hospital from A&E: rapid cost-effectiveness analysis.
    Stevenson M; Metry A; Messenger M
    Health Technol Assess; 2021 Mar; 25(21):1-68. PubMed ID: 33764295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of the confirmed cases and deaths of global COVID-19 using artificial intelligence.
    Guo Q; He Z
    Environ Sci Pollut Res Int; 2021 Mar; 28(9):11672-11682. PubMed ID: 33415612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Communicating uncertainty in epidemic models.
    McCabe R; Kont MD; Schmit N; Whittaker C; Løchen A; Walker PGT; Ghani AC; Ferguson NM; White PJ; Donnelly CA; Watson OJ
    Epidemics; 2021 Dec; 37():100520. PubMed ID: 34749076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.